Advertisement.

PVCTW Projected Dividend Yield

Provectus Biopharmaceuticals Inc ( OTCBB : PVCTW )

Provectus Biopharmaceuticals is a biotechnology company developing drugs based on halogenated xanthenes, such as Rose Bengal, which has a molecular formula of 4,5,6,7-tetrachloro-2',4',5',7'-tetraiodofluorescein. Co. is developing PV-10, a formulation of Rose Bengal, for direct injection into tumors as an investigational oncolytic immunotherapy, where it can destroy injected tumors (i.e., oncolytic) and elicit an anti-tumor immune response via the adaptive immune system (i.e., immunotherapy). Co. is also developing PH-10, an aqueous hydrogel formulation of Rose Bengal disodium, for topical administration to the skin for inflammatory dermatoses such as psoriasis and atopic dermatitis.

20 YEAR PERFORMANCE RESULTS

PVCTW Dividend History Detail
PVCTW Dividend News
PVCTW Competitors News

# of Shares: 0

Closing Price: 0.01

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000